Supran Bryan

Supran Bryan is listed in filings as EVP at Alnylam Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Mar 4, 2026, including 2 public disclosures. Recent filings connect the profile to Alnylam Pharmaceuticals Inc (ALNY). The current snapshot covers public activity from Mar 4, 2026. Reported amounts are shown as $1.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.